Your browser doesn't support javascript.
loading
Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study.
Matza, Mark A; Perugino, Cory A; Harvey, Liam; Fernandes, Ana D; Wallace, Zachary S; Liu, Hang; Allard-Chamard, Hugues; Pillai, Shiv; Stone, John H.
Afiliación
  • Matza MA; Division of Rheumatology, Allergy and Immunology. Massachusetts General Hospital. Harvard Medical School. 55 Fruit Street; Boston, MA 02114.
  • Perugino CA; Division of Rheumatology, Allergy and Immunology. Massachusetts General Hospital. Harvard Medical School. 55 Fruit Street; Boston, MA 02114.
  • Harvey L; Ragon Institute of MGH, MIT and Harvard. 400 Technology Square; Cambridge, MA 02139.
  • Fernandes AD; Division of Rheumatology, Allergy and Immunology. Massachusetts General Hospital. Harvard Medical School. 55 Fruit Street; Boston, MA 02114.
  • Wallace ZS; Division of Rheumatology, Allergy and Immunology. Massachusetts General Hospital. Harvard Medical School. 55 Fruit Street; Boston, MA 02114.
  • Liu H; Division of Rheumatology, Allergy and Immunology. Massachusetts General Hospital. Harvard Medical School. 55 Fruit Street; Boston, MA 02114.
  • Allard-Chamard H; Division of Rheumatology, Allergy and Immunology. Massachusetts General Hospital. Harvard Medical School. 55 Fruit Street; Boston, MA 02114.
  • Pillai S; Division of Rheumatology, Faculté de médecine et des sciences de la santé de l' Université de Sherbrooke et Centre de Recherche Clinique Étienne-Le Bel, Sherbrooke, Québec, Canada.
  • Stone JH; Ragon Institute of MGH, MIT and Harvard. 400 Technology Square; Cambridge, MA 02139.
Lancet Rheumatol ; 4(2): e105-e112, 2022 Feb.
Article en En | MEDLINE | ID: mdl-35425928

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lancet Rheumatol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lancet Rheumatol Año: 2022 Tipo del documento: Article